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The most frequent symptoms among the manifestations of cow milk protein allergy (CMPA) are gastrointestinal. CMPA
pathogenesis involves immunological mechanisms with participation of immunocompetent cells and production of
immunoglobulin E (IgE). Nevertheless, recent studies have been focused on the description of other forms of CMPA,
not-mediated by IgE reactions, mostly involving the T lymphocite immune system. Thus, in this field it is important to
note how different kind of cells are involved in the immunopathogenesis of CMPA, such as antigen-specific T cells, T
regulatory cells, cytokines secreted by the different T lymphocite subsets, B lymphocytes, antingen-presenting cells,
mast cells, that together orchestrate the complex mechanism leading to the phenotipic expression of CMPA.
The progress in the diagnosis of immunologic disorders allowed the recent literature to develop new models for
immuno-mediate disorders, involving new cells (such as Treg cells) and thus allowing the acquisition of a new vision of
the pathogenesis of atopic diseases.
The aim of this review is to describe the immunopathogenetic aspects of CMPA in view of these new discoveries in
the immunologic field, considering the immunologic pathway at the basis of both IgE- and not-IgE mediated CMPA.Introduction
The main role of the human gastrointestinal tract is the
reduction of ingested food in simple elements that can
be absorbed and used for energy production and cell
growth.
In order to prevent an indiscriminate immunization, sec-
ondary to the absorption of foreign antigens through the
gastrointestinal barrier, the gut has developed non specific
(non-immunological) mechanisms [1], such as the intestinal
mucosal barrier, the intestinal motility, secretion of mucus,
gastric acidity, enzymes, and specific (immunological) fac-
tors, such as the production of secretory IgA and antigen
interaction with the Gut Associated Lymphoid Tissue
(GALT) [2]. As a matter of fact, in normal individuals, anti-
gen presenting cells, mostly dendritic cells sited in the
GALT, play a main role in the development of a tolerogenic
response. They process the food antigen and present it on a
major histocompatibility complex (MHC) class II receptor
to the T cells, resulting physiologically in a status of imuno-
logic homeostasis known as “oral tolerance” by deletion or
inhibition of antigen-specific T cells and production of* Correspondence: giovitaliti@yahoo.it
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reproduction in any medium, provided the orregulatory T cells (Treg) that suppress inflammatory
responses to antigens [3,4].
The pathogenic mechanism of the mucosal tolerance
has not yet clarified. Recent studies have suggested that
human enterocytes could play a key role capturing sol-
uble antigens and selectively activating CD 8+ T cells
with a suppressive function [5].
Another explanation could be referred to a temporary
dysfunction of the protective mechanisms above described,
with a loss of tolerance and sensitization to food antigens.
As a matter of fact, it has been suggested that enterocytes
regulate the speed and the kind of absorption of ingested
antigens. On this regard it has been illustrated that mucus
has a major role as a barrier to foreign antigens, and food
proteins reaching the gut are partially digested by proteases
and by gastric acidity so that reduced gastric acidity in
infants and intake of proton pump inhibitors may play a
role in the pathogenesis of food allergy [6,7].
Approximately 50% of the protein absorption takes
place in the duodenum, even though the whole small
bowel is involved. These protein antigens may cross the
epithelial barrier by transcytosis through enterocytes or
by uptake via the Microfold cells (M-cells) [8,9]. Food
proteins may diffuse paracellularly through the epithelial
layer. In this case, the enhanced permeability is probablytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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kines [10]. In these cases, food proteins reach the MALT
in large quantities, most often leading to IgG induction
and immune complexes. So, the food-adverse reactions
may be immunologic, but not IgE-mediated [11].
There are literature studies evidencing that in genetic-
ally predisposed individuals sensitization of naive T cells
will lead to a TH2 type response with secretion of cyto-
kines [12]. In these cases a cell-mediated response deter-
mines local changes with a release of specific cytokines
and activation of Th2 lymphocytes (secreting IL-4, IL5,
IL10 and IL13), that promote the production of IgE and
amplify the inflammatory response (eosinophils, mast
cells, neutrophils and natural killers chemotaxis), caus-
ing morphological and functional alteration of the
mucosa [13,14].
Phenomena such as the increase of intestinal permeabil-
ity and circulating immune complexes, can be associated
with clinical symptoms in different organs and tissues,
and this data are confirmed by the fact that increased in-
testinal permeability is reduced by effective elimination
diet that excludes offending foods [15]. The higher inci-
dence of food allergy in infants seems to be linked to the
fact that infants are particularly prone to adverse reaction
to cow’s milk proteins. In newborns the digestive enzym-
atic activity is not fully active and the secretory IgA system
is not mature [16,17], The mucosa has an increased per-
meability shortly after birth [18]. For these reasons the
passage of undigested proteins causing a primed immune
response is facilitated. However, about 2% of the ingested
food proteins are absorbed in an immunologically intact
form also in adults [19].
The immunopathogenesis of cow’s milk allergy
The immunological mechanism that lead to the develop-
ment of cow’s milk allergy (or Cow’s Milk Protein
Allergy- CMPA) is not still clarified. There are different
mechanisms that contribute to the pathogenesis and the
main two described mechanisms at the basis of this
disease refer to IgE- and not-IgE- reactions [20]. Never-
theless, even if these two pathogenic pathways are the
main described, there is a third mechanism causing
CMPA, as a third group of symptoms attributed to cow’s
milk allergy are unpredictably associated with IgE anti-
body (IgE-associated/cell-mediated disorders) [21].
IgE-mediated reactions are based on simply immuno-
logical mechanisms that are better identified than not-
IgE-mediated ones. Since the onset of symptoms rapidly
evolves (from several minutes to several hours after
the contact with the allergen), this kind of mechanism is
referred as “immediate hypersensitivity”. This mechan-
ism developed in ancestors human beings to identify
multicellular target parasites and to build up an immune
response towards these organisms [22].IgE-mediated CMAP is characterized by two stages: the
first, of “sensibilization”, develops when the immune
system is programmed in an aberrant way, so that IgE
antibodies against cow milk proteins are secreted. These
antibodies bind the surface of mast cells and basophiles,
and the following exposure to milk proteins triggers the
“activation” phase, when IgE associated to mast cells bind
allergenic epitopes sited on milk proteins and unleash a
rapid release of inflammatory mediators responsible for
the allergic reaction. The allergens are ingested, processed
and expressed by antigens presenting cells (APC) [23].
The interaction between APC and T lymphocytes pro-
motes the modulation and the activation of B lymphocytes.
These latter produce IgE antibodies that interact by their
Fc portion with the allergen sited on mast-cells surface.
The interaction among allergens on mast-cells/basophiles
and IgE antibodies promotes an intracellular signalling
process with a consequent cell degranulation and a release
of histamine, PAF and other inflammatory mediators [24].
It is believed that both a deficiency in regulation and a
polarization of milk-specific T cells toward type-2 T helper
cells (TH2) lead to B-cell signaling to produce milk
protein-specific IgE. [25,26]. Treg dysfunction plays a
prominent role in lack of tolerance. It has also been shown
that children outgrow their cow’s milk allergy in associ-
ation with the development of Treg cells [27,28].
In some patients there is independent immunological tol-
erance to cow’s milk and exercise. However, anaphylaxis
occurs when exercise followed intake of food (food
dependent exercise-induced anaphylaxis) [29,30]. The exer-
cise may induce serum hyperosmolality which increases
histamine release [31] . Other possible explanations are that
exercise may trigger the reaction since it decreases serum
pH [32], or increases gastrointestinal permeability [33].
A high percentage of children and adults does not
show circulating IgE specific for cow’s milk proteins and
their skin prick test and serum specific IgE antibodies
result negative. This occurs for the development of a
not-IgE-mediated allergic disease. These reactions are
characterized by a delayed set up, associated with the
onset of symptoms after one hour or many days after
the ingestion of cow’s milk proteins. For this reason,
these reactions are classified as “delayed hypersensitiv-
ity”. However it is important to explain that the two
reactions above described are not mutually exclusive and
both can act in the same disease through different path-
ways [34].
The pathogenesis of non-IgE mediated reactions is
supported by different theories: reactions mediated by
Th1 cells, interactions between T lymphocytes, mast
cells and neurons that alters the function of the smooth
muscle and the intestinal motility [35].
It seems that there are discrepancies between the high
number of natural resolution of manifestations linked to
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predominance of these reactions in adulthood. This the-
ory explains as these kind of reactions can appear later
in life. On this regard, Zuberbier et al. observed patients
of different age and they found a direct relationship be-
tween the incidence of not-IgE -mediated reactions and
age. Nevertheless, other studies are needed to confirm
this hypothesis [36].
T lymphocytes and the induction of mucosal tolerance in
CMPA
In food allergy the fine balance between mucosal toler-
ance and hypersensitivity is regulated by the immune
system. This complex system includes molecules with
regulatory properties, such as Transforming Growth
Factor Beta 1 (TGF-beta1), IL-10 and Natural Killers.
TGF-beta 1 and IL-10 are actually known as tolerogenic
cytokines, produced by Treg, that are cells thought to
regulate the immune system [37]. Also CD4+CD25 +
Foxp3+ T cells are described as important mediators for
maintaining peripheral tolerance and suppressing the T
lymphocytes proliferation [38,39].
A decreased immune response towards foreign
antigens is defined as “mucosal or oral tolerance”, char-
acterized by the deletion or suppression of T reactive
specific-antigen cells and by production of T regulatory
cells (Treg) that suppress the inflammatory response
against benign antigens [39-44]. A dysfunction on Treg
cellular activity seems to be a necessary background for
the spread of both reactions (IgE- and not-IgE mediated
CMPA), as the induction of mucosal tolerance in chil-
dren is linked with an increase of Treg lymphocytes
[45].
Actually, there are studies in progress with the aim to
manipulate dendritic cells (specific cells presenting the
antigen) as to improve the Treg function and/or to
reestablish the Th1/Th2 balance and to promote the tol-
erance towards food antigens [46,47].
The Treg cells are about 5-10% of CD4+ T lympho-
cytes. They express the transcription factor “forkhead
box” (FOXp3), that is a key gene for the generation and
the maintenance of T lymphocytes [39]. To date, the
involvement of Treg cells in the induction of oral toler-
ance is little known [48].
There are two distinct phases in the development of
mucosal tolerance: the clonal deletion and the active
suppression of the immune response, and it seems that
Treg cells mediate both phases.
In vivo the depletion of anti-CD25 antibodies demon-
strated that Treg play an important role in the oral
sensitization to serum cow’s milk protein in mice
(unpublished data by B. van Esch, B. Blokhuis, G. Hofman,
L. Boon, J. Garssen, L. Knipples, L. Willemsen and
F. Redegeld).Further, Gri et al. demonstrated that Treg cells directly
inhibit the mast cell degranulation through cell-cell con-
tact and secretion of IL-10. In vivo depletion or inactiva-
tion of Treg cells causes enhancement of the anaphylactic
response [40].
McNeil et al. investigated the role that Treg play in
modulation of the human response. The authors showed
that a previous treatment with the CD25 PC61 MoAb
(monoclonal Antibodies) depleted a subpopulation of
Treg in mice. In addition, PC61 seemed to alter the func-
tion of the remaining regulatory T cell population prevent-
ing their ability to modulate autoimmune diseases [44].
In conclusion, it seems that T lymphocytes subsets
play a key role in allergic reactions to cow’s milk pro-
teins, above all in those not-IgE mediated, and Treg cells
are at the basis of oral tolerance to food allergy, so that
an altered pattern of the immune system leads to all
those atopic reactions, that are not explained by an IgE
background [49].
Probiotics and immune system: a new vision of the
intestinal microbiota in CMPA
Toll like receptor (TLRs) recognize specific bacterial
surface markers of microbiota, so called PAMP (Patho-
gen-associated molecular patterns) [50]. Some TLR
agonists may activate Treg cells while others may trigger
an allergic sensitization [51]. It could be possible that in
industrialized societies, a decreased microbial exposure
in early life leads to T-cell dysregulation which induce
allergic disorders [52]. It is therefore, of great interest
the characterization of probiotics bacterial strains that
protect from sensitization to food allergens.
It is demonstrated that some chains of Lactobacillus
and Bifidus Bacteria may influence the immune func-
tions through different immunological mechanisms that
act on enterocytes, antigen presenting cells, Treg and T
and B effector lymphocytes [53-55].
In the gut, commensal bacteria allow a reduction of
local inflammatory reactions. A single probiotic chain is
necessary to maintain the integrity of the gut barrier re-
ducing the effect of the antigen load. Some of these
effects seem to be mediated by Treg, TLR9, TLR2 and
TLR4. The intestinal microbiota also promotes the pro-
duction of TNF-α and PGE2 that interfere with the
development of tolerance mediated by dendritic cells
[56]. As a matter of fact, an upregulation of TNF-α ex-
pression was found in gastrointestinal tract and in
lesional skin of patients with acute urticaria [55]. In
addition, most of the children with milk-induced cutane-
ous symptoms who showed an increased TNF-α secre-
tion from milk-stimulated PBMCs were children with
urticaria [57]. On this regard, other studies showed that
probiotics directly potentiate the activity of human den-
dritic cells in promoting the polarization towards Th1.
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mune regulation and the allergenic tolerance [46].
In animal studies, probiotic supplementation seems to
induce the development of Treg. In vitro human studies
also suggest an increase of cytokine production (IL10)
after ingestion of probiotics. This effect is limited only
to certain species, such as L. Reuteri and L. Casei but
doesn’t involve other species such as L. Plantarum. It is
shown that L. Reiteri and L. Casei stimulate dendritic
cells to increase the production of Treg cells. These lat-
ter produce high levels of IL10, inhibiting the activation
of effector T lymphocytes [58,59].
These two lactobacilli are able to bind an intercellular
lecitine-like adhesion molecule, specific for dendritic
cells (know as non integrin grabbing molecule 3), block-
ing the interaction between the antibodies and these
molecules [60,61]. Therefore probiotics show a positive
effect in the induction of Treg cells.
The intestinal microbiota also influence the produc-
tion of IgA in the distal intestinal tract. The gastrointes-
tinal area plays a crucial role as integral part associated
with the mucosal immune system. Currently it is widely
described that B cells and effector T cells, sited in the
gastrointestinal mucosa, develop also in the respiratory
tract. This could explain why the intestinal microbiota
can stimulate a systemic Th1 response.
It is unclear how probiotics can influence cell popula-
tions derived from bone marrow that do not pass
through the intestine at any stage of maturation. In
infant animals it is demonstrated that the presence of
circulating monocytes mature in different ways depend-
ing on exposure to intestinal microflora. Many studies
supporting the potential effects of the bone marrow
showed that changes in gut microflora have a significant
influence on the bone progenitor CD34cells release into
circulation. Thus, a better understanding of the potential
action of the intestinal microbiota is necessary for the
assessment of possible causal effects and the role of pro-
biotics as agents for prevention and therapy of atopic
diseases, such as CMPA.
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